Protocol registration – SGLT2 inhibitors increase 3-fold the risk of diabetic ketoacidosis in patients with type 2 diabetes

Protocol registration – SGLT2 inhibitors increase 3-fold the risk of diabetic ketoacidosis in patients with type 2 diabetes

Redirecting to Project: SGLT2 inhibitors and risk of diabetic ketoacidosis (Q18-11)